The North America Dystonia Drugs Market would witness market growth of 4.8% CAGR during the forecast period (2022-2028).
Dystonia is classified according to three primary factors: the age at which symptoms manifest, the affected body regions, and the underlying reason. The likelihood that several body parts will be affected by dystonia is often proportional to the age of onset. The younger one is at the outset of symptoms, the greater the likelihood they may spread. In contrast, the greater the period in the beginning, the greater the likelihood that the disease will remain mild.
The neck (cervical dystonia or spasmodic torticollis), eyes (blepharospasm), jaw/mouth/lower face (oromandibular dystonia), vocal cords (laryngeal dystonia), or arms/legs might be affected by focal dystonia (limb dystonia). Other less common types of focal dystonias might involve abnormal stretching, bending, or twisting of the trunk (truncal dystonia), persistent contractions, and involuntary abdominal wall writhing (abdominal wall dystonia). Focal dystonia affects persons in their 40s and 50s more frequently and is commonly referred to as adult-onset dystonia. Around three times more women are impacted than men. Focal dystonias are typically classed as primary (idiopathic) and are not inherited.
The American healthcare system is a hub for innovation that creates and widely disseminates cutting-edge, life-improving therapies and provides healthcare consumers with a wide range of options. There are many advantages to the existing healthcare system. Also, the government is working on many areas where improvements may be made to lower prices, broaden access, raise quality, and improve Americans' health. HHS (Health and Human Services) aims to safeguard and provide accessible, high-quality healthcare equitably. The Department's activities are concentrated on lowering costs, enhancing the quality of healthcare services, assuring access to safe medical devices and medications, and expanding choice, affordability, and enrollment in high-quality healthcare coverage.
The US market dominated the North America Dystonia Drugs Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $317 Million by 2028. The Canada market is poised to grow at a CAGR of 6.8% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 6.5% during (2022 - 2028).
Based on Distribution Channel, the market is segmented into Drug Stores & Retail Pharmacies, Hospital Pharmacies and Online Providers. Based on Route of Administration, the market is segmented into Oral and Injectable. Based on Type, the market is segmented into GABAergic Agents, Dopaminergic Agents, Anticonvulsants Drugs and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Dystonia Drugs Market is Estimated to reach $1.1 Billion by 2028, at a CAGR of 5.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Pfizer, Inc., Novartis AG, Teva Pharmaceuticals Industries Ltd., AbbVie, Inc., F. Hoffmann-La Roche Ltd., Ipsen Pharma Biotech SAS, Hameln Pharma Gmbh (Siegfried Group, LLP), Amneal Pharmaceuticals, Inc., Merz Pharma GmbH & Co. KGaA, and Wellona Pharma.
Scope of the Study
Market Segments Covered in the Report:
By Distribution Channel
- Drug Stores & Retail Pharmacies
- Hospital Pharmacies
- Online Providers
By Route of Administration
By Type
- GABAergic Agents
- Dopaminergic Agents
- Anticonvulsants Drugs
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Pfizer, Inc.
- Novartis AG
- Teva Pharmaceuticals Industries Ltd.
- AbbVie, Inc.
- F.Hoffmann-La Roche Ltd.
- Ipsen Pharma Biotech SAS
- Hameln Pharma Gmbh (Siegfried Group, LLP)
- Amneal Pharmaceuticals, Inc.
- Merz Pharma GmbH & Co. KGaA
- Wellona Pharma
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Dystonia Drugs Market, by Distribution Channel
1.4.2 North America Dystonia Drugs Market, by Route of Administration
1.4.3 North America Dystonia Drugs Market, by Type
1.4.4 North America Dystonia Drugs Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition & scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Dystonia Drugs Market by Distribution Channel
3.1 North America Drug Stores & Retail Pharmacies Market by Country
3.2 North America Hospital Pharmacies Market by Country
3.3 North America Online Providers Market by Country
Chapter 4. North America Dystonia Drugs Market by Route of Administration
4.1 North America Oral Market by Country
4.2 North America Injectable Market by Country
Chapter 5. North America Dystonia Drugs Market by Type
5.1 North America GABAergic Agents Market by Country
5.2 North America Dopaminergic Agents Market by Country
5.3 North America Anticonvulsants Drugs Market by Country
5.4 North America Others Market by Country
Chapter 6. North America Dystonia Drugs Market by Country
6.1 US Dystonia Drugs Market
6.1.1 US Dystonia Drugs Market by Distribution Channel
6.1.2 US Dystonia Drugs Market by Route of Administration
6.1.3 US Dystonia Drugs Market by Type
6.2 Canada Dystonia Drugs Market
6.2.1 Canada Dystonia Drugs Market by Distribution Channel
6.2.2 Canada Dystonia Drugs Market by Route of Administration
6.2.3 Canada Dystonia Drugs Market by Type
6.3 Mexico Dystonia Drugs Market
6.3.1 Mexico Dystonia Drugs Market by Distribution Channel
6.3.2 Mexico Dystonia Drugs Market by Route of Administration
6.3.3 Mexico Dystonia Drugs Market by Type
6.4 Rest of North America Dystonia Drugs Market
6.4.1 Rest of North America Dystonia Drugs Market by Distribution Channel
6.4.2 Rest of North America Dystonia Drugs Market by Route of Administration
6.4.3 Rest of North America Dystonia Drugs Market by Type
Chapter 7. Company Profiles
7.1 Pfizer, Inc.
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional & Segmental Analysis
7.1.4 Research & Development Expense
7.2 Novartis AG
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.3 Teva Pharmaceutical Industries Ltd.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Product Launches and Product Expansions:
7.4 AbbVie, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Regional Analysis
7.4.4 Research & Development Expense
7.5 F. Hoffmann-La Roche Ltd.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.6 Ipsen Pharma Biotech SAS
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expense
7.7 Hameln Pharma Gmbh (Siegfried Group, LLP)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Research & Development Expenses
7.8 Amneal Pharmaceuticals, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental Analysis
7.8.4 Research & Development Expenses
7.9 Merz Pharma GmbH & Co. KGaA
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Approvals and Trials:
7.10. Wellona Pharma
7.10.1 Company Overview
TABLE 1 North America Dystonia Drugs Market, 2018 - 2021, USD Million
TABLE 2 North America Dystonia Drugs Market, 2022 - 2028, USD Million
TABLE 3 North America Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 4 North America Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 5 North America Drug Stores & Retail Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 6 North America Drug Stores & Retail Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 7 North America Hospital Pharmacies Market by Country, 2018 - 2021, USD Million
TABLE 8 North America Hospital Pharmacies Market by Country, 2022 - 2028, USD Million
TABLE 9 North America Online Providers Market by Country, 2018 - 2021, USD Million
TABLE 10 North America Online Providers Market by Country, 2022 - 2028, USD Million
TABLE 11 North America Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 12 North America Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 13 North America Oral Market by Country, 2018 - 2021, USD Million
TABLE 14 North America Oral Market by Country, 2022 - 2028, USD Million
TABLE 15 North America Injectable Market by Country, 2018 - 2021, USD Million
TABLE 16 North America Injectable Market by Country, 2022 - 2028, USD Million
TABLE 17 North America Dystonia Drugs Market by Type, 2018 - 2021, USD Million
TABLE 18 North America Dystonia Drugs Market by Type, 2022 - 2028, USD Million
TABLE 19 North America GABAergic Agents Market by Country, 2018 - 2021, USD Million
TABLE 20 North America GABAergic Agents Market by Country, 2022 - 2028, USD Million
TABLE 21 North America Dopaminergic Agents Market by Country, 2018 - 2021, USD Million
TABLE 22 North America Dopaminergic Agents Market by Country, 2022 - 2028, USD Million
TABLE 23 North America Anticonvulsants Drugs Market by Country, 2018 - 2021, USD Million
TABLE 24 North America Anticonvulsants Drugs Market by Country, 2022 - 2028, USD Million
TABLE 25 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 26 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 27 North America Dystonia Drugs Market by Country, 2018 - 2021, USD Million
TABLE 28 North America Dystonia Drugs Market by Country, 2022 - 2028, USD Million
TABLE 29 US Dystonia Drugs Market, 2018 - 2021, USD Million
TABLE 30 US Dystonia Drugs Market, 2022 - 2028, USD Million
TABLE 31 US Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 32 US Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 33 US Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 34 US Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 35 US Dystonia Drugs Market by Type, 2018 - 2021, USD Million
TABLE 36 US Dystonia Drugs Market by Type, 2022 - 2028, USD Million
TABLE 37 Canada Dystonia Drugs Market, 2018 - 2021, USD Million
TABLE 38 Canada Dystonia Drugs Market, 2022 - 2028, USD Million
TABLE 39 Canada Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 40 Canada Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 41 Canada Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 42 Canada Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 43 Canada Dystonia Drugs Market by Type, 2018 - 2021, USD Million
TABLE 44 Canada Dystonia Drugs Market by Type, 2022 - 2028, USD Million
TABLE 45 Mexico Dystonia Drugs Market, 2018 - 2021, USD Million
TABLE 46 Mexico Dystonia Drugs Market, 2022 - 2028, USD Million
TABLE 47 Mexico Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 48 Mexico Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 49 Mexico Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 50 Mexico Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 51 Mexico Dystonia Drugs Market by Type, 2018 - 2021, USD Million
TABLE 52 Mexico Dystonia Drugs Market by Type, 2022 - 2028, USD Million
TABLE 53 Rest of North America Dystonia Drugs Market, 2018 - 2021, USD Million
TABLE 54 Rest of North America Dystonia Drugs Market, 2022 - 2028, USD Million
TABLE 55 Rest of North America Dystonia Drugs Market by Distribution Channel, 2018 - 2021, USD Million
TABLE 56 Rest of North America Dystonia Drugs Market by Distribution Channel, 2022 - 2028, USD Million
TABLE 57 Rest of North America Dystonia Drugs Market by Route of Administration, 2018 - 2021, USD Million
TABLE 58 Rest of North America Dystonia Drugs Market by Route of Administration, 2022 - 2028, USD Million
TABLE 59 Rest of North America Dystonia Drugs Market by Type, 2018 - 2021, USD Million
TABLE 60 Rest of North America Dystonia Drugs Market by Type, 2022 - 2028, USD Million
TABLE 61 Key Information – Pfizer, Inc.
TABLE 62 Key Information – Novartis AG
TABLE 63 Key Information – Teva Pharmaceuticals Industries Ltd.
TABLE 64 Key information – AbbVie, Inc.
TABLE 65 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 66 Key Information – Ipsen Pharma Biotech SAS
TABLE 67 Key Information – Hameln Pharma Gmbh
TABLE 68 Key Information – Amneal Pharmaceuticals, INc.
TABLE 69 Key information – Merz Pharma GmbH & Co. KGaA
TABLE 70 Key Information – Wellona Pharma
List of Figures
FIG 1 Methodology for the research